Oshkosh, Wis. – January 29, 2009 – Fox Valley Plastic Surgery, Wisconsin’s choice for cosmetic surgery, has been authorized to provide Latisse® on a prescription basis to patients. Latisse®, manufactured by Allergan, is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness.
Latisse® contains bimathoprost, which was first approved in 2001 as a medical product to lower intraocular pressure in people with open-angle glaucoma or ocular hypertension. A side effect of the analog with patients who have used it is longer and fuller lashes. The Food and Drug Administration (FDA) approved Latisse® in December, 2008.
Cathy Hagene, practice manager for Fox Valley Plastic Surgery and the Renaissance MediSpa, believes the product will be popular with female patients in Wisconsin and the Upper Peninsula of Michigan. “In winter, all you can show off is your face. Longer eyelashes will be a natural-looking, beautiful addition many women will enjoy.”
Fox Valley Plastic Surgery and the Renaissance MediSpa will begin offering Latisse® in mid-February.
About Fox Valley Plastic Surgery and the Renaissance MediSpa
The 25 professionals at Fox Valley Plastic Surgery in Oshkosh, Wisconsin offer facial aesthetics, breast surgery, body contouring, facial plastic surgery and medispa services. Drs David Janssen and William Doubek are certified by the American Board of Plastic Surgery and members of the American Society of Plastic Surgeons. Dr. Janssen is also a member of the American Society of Aesthetic Plastic Surgery (ASAPS). Only one quarter of all practicing plastic surgeons belong to ASAPS. For more information on Fox Valley Plastic Surgery, please visit www.fvpsurgery.com.
Important Latisse® Safety Information from Allergan, manufacturer of Latisse®
Latisse® solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN® or other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use Latisse® under the close supervision of your doctor.
Latisse® use may cause darkening of the eyelid skin which may be reversible. Although not reported in clinical studies, Latisse® use may also cause increased brown pigmentation of the colored part of the eye which is likely to be permanent.
It is possible for hair growth to occur in other areas of your skin that Latisse® frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this from happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if you stop using Latisse®.
The most common side effects after using Latisse® solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. Latisse® solution may cause other less common side effects which typically occur on the skin close to where Latisse® is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your doctor’s advice concerning the continued use of Latisse® solution.
Full prescribing information is available at www.latisse.com and www.allergan.com.
Oshkosh, WI (920) 233-1540